Manufacturing and Analytical Services
Which Dosage Form Gets Your Drug to Market Faster?
Liquid-Filled Capsules ― Getting Your Drug to Market, Fast
Altasciences has developed and manufactured practically every dosage form on the market, and our experts agree that liquid-filled, two-piece, hard-shell capsules (LFCs) offer several advantages over other solid dosage forms, such as ease of scalability and manufacturing, faster absorption, simpler packaging, and excellent product stability.
With LFCs, scientists can effectively formulate poorly soluble drugs, while reducing development time and costs.
Watch our Executive Vice President of Operations, Ben Reed, explain in more detail.
Are liquid-filled capsules suitable for your API? Speak with an expert to find out.
You may also be interested in the following:
- Webpage: Pharmaceutical Contract Manufacturing Services
- Webpage: Analytical Laboratory Services
- Webinar: Manufacturing Solutions Using Liquid-Filled Capsules
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.
Liquid-Filled Capsules — an Attractive, Marketable Solution
A Scalable Solution for Solubility Challenges
Poorly soluble molecules comprise more than 70% to 80%1 of the small molecule products entering the
Your CDMO Partner, from Discovery to Commercialization
Whether for a single study or a full drug development program, Altasciences can support you. We offer contract manufacturing and analytical services, including formulation development, Phase I through commercial manufacturing, and ICH stability testing.
Our integrated and synchronized approach to CRO and CDMO services, all under one organizational structure, can save you 25% to 40% in drug development time.
Watch our Executive Vice President of Operations, Ben Reed, discuss our expertise in more detail.
Questions? Speak with an expert!
You may also be interested in the following:
High Potency Drug Manufacturing Solutions for Your Program
Altasciences’ CDMO facility is equipped to manufacture and handle highly potent compounds.
- Scalable, segregated, flexible, GMP high potency/Grade C and D clean rooms with dedicated air handling for potent compounds
- State-of-the-art equipment for safe, effective manufacture of your potent materials, from clinical through commercialization
- Formulation and product development
- Multiple dose capabilities
Listen to the podcast to learn more on how Altasciences handles and manufactures highly potent pharmaceutical ingredients, the equipment used, and the rigorous processes in place to ensure your program's success, safely.
 |
 |
| Ben Reed Executive Vice President, Operations Altasciences breed@altasciences.com |
Shawn J. Connaghan Vice President, Quality Assurance Altasciences sconnaghan@altasciences.com |
Do you have questions? Speak with an expert.
You may also be interested in the following:
- Webpage: Overview of our Pharmaceutical Contract Manufacturing Services
- Video: Altasciences’ Manufacturing & Analytical Solutions
- Video: Benefits of Liquid-Filled Capsule Manufacturing
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining solutions, whether a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.
Take a Tour of our State-of-the-Art Manufacturing and Analytical Facility
From formulation to commercialization, Altasciences’ 64,000 square-foot, purpose-built FDA-inspected GMP facility features an analytical lab, a Research & Development formulations lab, and multiple manufacturing suites with cutting-edge Grade C cleanrooms, including segregated and dedicated potent handling areas. Our CDMO experts have over 100 years of combined experience in the management of pharmaceutical manufacturing and laboratory operations.
Our expertise includes:
- Liquid and powder-filled capsules
- Nano-milled suspensions
- Creams
- Powders
- Terminally sterilized injectables
Catch a glimpse of the facility here.
Request a full virtual tour of our Philadelphia site today or contact us.
You may also be interested in the following:
- Webpage: Pharmaceutical Contract Manufacturing and Analytical Services
- The Altascientist: Maximizing Drug Formulation for First-in-Human Trials
- Webinar: Overcoming the Challenges of Manufacturing and Clinical Trials
- Podcast: Altasciences’ Manufacturing Solutions, Liquid-Filled Capsules
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.
Small Molecule, Nonclinical Drug Development Solutions
As your drug development partner, we have a deep appreciation of both the challenges and the potential of your small molecule. At Altasciences, we understand why developing your molecule requires tailored solutions at every stage.
Find out how our small molecule solutions help identify new and improved approaches to study designs, and anticipate development challenges as studies evolve.
Bring us your challenge. We have the solution.
You may also be interested in the following:
- Factsheet: Small Molecule Safety Assessment
- IND/CTA Guide: Planning your Preclinical Assessment
- Webpage: Bioanalytical Services
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.
Securing VC Funding and Drug Manufacturing Consulting
Consultant Series ― Interview with Teresa Johnk
Listen in as we discuss the role of a strategic business development consultant in drug development with industry veteran Teresa Johnk, Founder and CEO of BioPharma Connections.
In this podcast, we uncover:
- Important considerations to secure VC funding
- How to ensure the successful program completion
- What to look for in a consultant
- What to look for in a CRO/CDMO partner
Connect with our industry experts.
You may also be interested in the following:
- Webinar: Overcoming the Challenges of Manufacturing and Clinical Trials
- Factsheet: Manufacturing and Analytical Services
- Webpage: Full-Time Equivalent (FTE) Capabilities
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.
25+ Years’ Experience Conducting Early Phase Drug Development
One of the most significant milestones in drug development research is the transition from preclinical to clinical studies. Ensuring risk mitigation at all steps of preclinical and clinical testing, as well as incorporating a thorough safety review plan in the clinical setting, is integral.
Altasciences applies recommendations from world-wide regulatory agencies to ensure that studies are conducted safely, ethically, and in a scientifically robust manner.
We facilitate drug development and save you time by:
- Preparing your preclinical study designs, including species selection and dose level determination.
- Conducting the required safety testing and updating your Investigational Brochure while your IND/CTA-enabling studies are in progress.
- Writing your IND/CTA applications.
- Planning your clinical program while your preclinical safety assessment is ongoing so that you can initiate your first-in-human (FIH) trials as soon as you receive regulatory approval.
- Designing your FIH clinical protocol using preclinical study data, including identifying the maximum safe starting doses.
- Timing small-scale drug formulations with clinical conduct to get your trials started sooner.
- Conducting your FIH trials and making quick, informed dosing decisions based on timed bioanalytical data and safety data available within 48 hours.
- Quickly identifying trial findings that may allow you to waive certain studies or provide critical data for safety/dosing considerations in subsequent clinical studies.
Our preclinical, manufacturing, bioanalytical, and clinical teams work closely together to transition drugs through the critical early phases of drug development.
Speak with our experts.
You may also be interested in the following:
- Video: Your Road to Proactive Drug Development with Altasciences
- Webpage: Scientific, Regulatory and Strategic Guidance
- Webpage: Full-Time Equivalent (FTE) Capabilities
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining solutions, whether a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.
Formulation Development Services
Altasciences offers extensive and comprehensive formulation development services for your preclinical toxicology programs.
Our Analytical Chemistry experts regularly develop a vast array of formulation types (for both oral and parenteral administration) and offer a comprehensive package of formulation development from preformulation investigations, formulation validations, stability assessments, compatibility (e.g., with filters and catheters), and assessment of suitability with dosing apparatus. A combination of our formulation expertise, knowledge of vehicle suitability in preclinical models and close collaboration with our toxicologists ensures the development of a vast array of formulation types suitable for preclinical programs.
Oral
- Solutions
- Suspensions
- Emulsions
- Pills
Parenteral
- Intravenous (bolus and continuous)
- Subcutaneous
- Intraperitoneal
- Intramuscular
- Intravitreal
Download our one-pager to learn more.
Contact our scientists for a customized experience.
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining solutions, whether a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.
You may also be interested in the following:
Fact Sheet: